Premium
Cisplatin‐resistant osteosarcoma cell‐derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801‐dependent manner
Author(s) -
Pan Yuanxing,
Lin Yunfei,
Mi Chuan
Publication year - 2021
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1002/cbin.11532
Subject(s) - microvesicles , cisplatin , exosome , downregulation and upregulation , cancer research , osteosarcoma , apoptosis , chemistry , p glycoprotein , drug resistance , microrna , multiple drug resistance , biology , medicine , chemotherapy , gene , biochemistry , microbiology and biotechnology
Studies have shown that exosomes can mediate the chemoresistance of drug‐resistant cells by transmitting circular RNAs (circRNAs). However, the role of exosome‐derived hsa_circ_103801 (exosomal hsa_circ_103801) in osteosarcoma (OS) remains unclear. The level of hsa_circ_103801 was upregulated in the serum exosomes from patients with OS, and OS patients with high hsa_circRNA_103801 expression had a shorter survival time relative to patients with low hsa_circ_103801 expression. The expression of hsa_circ_103801 was upregulated in cisplatin‐resistant MG63 (MG63/CDDP) cells compared with that in MG63 cells. In addition, hsa_circ_103801 was highly enriched in exosomes derived from CDDP‐resistant OS cells and could be delivered to MG63 and U2OS cells through exosomes. Exosomes derived from CDDP‐resistant cells were shown to reduce the sensitivity of MG63 and U2OS cells to CDDP, inhibit apoptosis, and increase the expression of multidrug resistance‐associated protein 1 and P‐glycoprotein. Moreover, exosomal hsa_circ_103801 could strengthen the promotive effect of exosomes on the chemoresistance of MG63 and U2OS cells to CDDP. Hence, serum exosomal hsa_circ_103801 may serve as an effective prognostic biomarker for OS, and exosomal hsa_circ_103801 could be a potential target for overcoming OS chemoresistance.